A Study of Human Substance Balance and Biotransformation of [14C]SHR0302

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

September 19, 2021

Study Completion Date

June 8, 2022

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG

SHR0302、[14C]SHR0302

8 mg SHR0302/ 80 µCi \[14C\]SHR0302, once, D1

Trial Locations (1)

the first affiliated hospital of Soochow University, Suzhou

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05047341 - A Study of Human Substance Balance and Biotransformation of [14C]SHR0302 | Biotech Hunter | Biotech Hunter